Translocations of the retinoic acid receptor-a (RARa) locus with the promyelocytic leukemia zinc-finger (PLZF) or PML genes lead to expression of oncogenic PLZFRARa or PML-RARa fusion proteins, respectively. These fusion oncoproteins constitutively repress RARa target genes, in large part through aberrant recruitment of multiprotein co-repressor complexes. PML and PMLRARa have previously been shown to associate with the retinoblastoma (Rb) tumour suppressor protein in its hypophosphorylated state. Here, we demonstrate that PLZF also interacts with Rb in vitro and in vivo. The interaction between PLZF and Rb is mediated through the Rb pocket and the region of PLZF that lies between its transcriptional repression (poxvirus and zinc-finger, POZ) and DNA-binding (zinc-finger) domains. In addition, Rb can simultaneously interact with PLZF and the E2F1 S phase-inducing transcription factor, suggesting that these proteins can exist in the same multiprotein complex. In contrast to the interaction of Rb with PML or E2F1, the PLZF-Rb interaction is not dependent on hypophosphorylation of Rb. These data are supported by chromatin immunoprecipitation analysis, which indicates that PLZF associates with the promoter region of CDC6, a known E2F/Rb target gene. Co-expression of PLZF and Rb results in enhancement of transcriptional repression of PLZF and E2F/Rb target genes, indicating functional co-operation between the two proteins. Both PLZF and Rb have been shown to function in stem cells and taken together these data suggest that interactions between PLZF and Rb could be important in stem cell biology.
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The PLZF (promyelocytic leukemia zinc-finger) gene was originally identified as a result of the t(11;17) translocation with the retinoic acid receptor-a (RARa) locus that gives rise to the PLZF-RARa fusion oncoprotein in acute promyelocytic leukemia (APL). PLZF is a member of the BTB/POZ-ZF family of transcriptional repressors, which also includes BCL6, LRF, Kaiso and FAZF (Kelly and Daniel, 2006) . These proteins are characterized by the presence of a conserved N-terminal poxvirus and zinc-finger (POZ) domain that mediates protein-protein interactions and transcriptional repression, as well as C-terminal Kru¨ppel-type zinc-fingers that define sequence-specific DNA binding. The t(11;17) translocation is the second most common involving the RARa gene, with the majority of APL cases possessing the PML-RARa associated t(15;17). Several other very rare translocations involving RARa have also been discovered (Zelent et al., 2001) . Although both PLZF-RARa and PML-RARa fusion proteins constitutively repress RARa target genes, only PML-RARa associated APL responds remarkably well to treatment with all-trans-retinoic acid (ATRA) and has served as a paradigm for differentiation therapy (Warrell, 1997) . The lack of ATRA responsiveness in PLZF-RARa associated APL compared to PML-RARa is due to distinct interactions of the fusion oncoprotein with histone deacetylase (HDAC)-containing co-repressor complexes, which are mediated via the PLZF moiety (Hong et al., 1997; Grignani et al., 1998; Guidez et al., 1998; He et al., 1998; Lin et al., 1998) .
Mice lacking PLZF (also known as ZNF145) exhibit defects in patterning of the limb and axial skeleton (Barna et al., 2000) , although a hematopoietic phenotype, if any exists, has not yet been described. However, studies of PLZF expression and function in cultured murine and human hematopoietic cells suggest that it inhibits differentiation (Shaknovich et al., 1998) and may play a role in maintenance of the hematopoietic stem cell pool (Reid et al., 1995; Licht et al., 1996) . Moreover, a number of studies have indicated that cellcycle regulators (Yeyati et al., 1999; McConnell et al., 2003) and Hox genes are major targets of this transcription factor (Barna et al., 2000 (Barna et al., , 2002 Ivins et al., 2003) .
The retinoblastoma (Rb) tumour suppressor protein connects the cell-cycle clock and transcriptional control of genes (Giacinti and Giordano, 2006) . Thus, it plays a critical role in the inhibition of cellular proliferation, a fact underscored by its inactivation in many human tumours. Major targets of Rb are genes required for cell-cycle progression that are under the control of the E2F/DP family of transcription factors (Giacinti and Giordano, 2006) . In addition to E2F family members, more than 100 proteins have been found to associate with Rb either directly or as part of a complex, and many of these interacting proteins also have transcriptional regulatory roles (Morris and Dyson, 2001 ). In its role as a transcriptional repressor, Rb assembles multiprotein complexes containing the SWI/SNF nucleosome remodelling machinery and epigenetic modifiers such as HDACs, the SUV39H1 lysine methyltransferase and the DNMT1 DNA methyltransferase (Macaluso et al., 2006) . Rb has also recently been shown to recruit the arginine methyltransferase PRMT2, which repressed E2F1 transcriptional activity in a Rb-dependent manner (Yoshimoto et al., 2006) .
Given the documented interaction of PML and PMLRARa with Rb (Alcalay et al., 1998; Labbaye et al., 1999; Khan et al., 2001) , we sought to investigate whether PLZF and PLZF-RARa also associated with this transcriptional repressor. Pull-down assays using bacterially expressed GST-Rb or GST-PLZF and These test proteins were then used in pull-down assays with GST-Rb. Pull-downs with GST protein alone are shown as negative controls. Inputs correspond to 10% of 35 S-methionine labelled protein as indicated. All GST fusion proteins were prepared using standard procedures (Dong et al., 1996) . 35 S-methionine-labelled proteins were synthesized in vitro using a coupled reticulocyte lysate system (TNT, Promega). In vitro interaction pull-down assays were performed as previously described . Mammalian cDNA expression vectors for PML, PLZF, 5 0 PLZF (encoding amino acids 1-455 of PLZF, but lacking the last seven C-terminal zinc-fingers), poxvirus and zinc-finger (POZ) domain (encoding the N-terminal amino acids 1-120 of PLZF) and the GST-PLZF plasmid have been previously described (Chen et al., 1994; Dong et al., 1996; Guidez et al., 1998) . Expression vectors for E2F1 (Hsieh et al., 1997) , Rb (Chew et al., 1998) and GST-Rb (full-length and deletions) (Zarkowska and Mittnacht, 1997) have also been previously described. (Figure 1c ). This region encompasses the acidic and proline-rich motifs and the first two zinc-fingers but lies outside of the POZ domain and does not contain the last seven C-terminal zinc-fingers, although multiple contacts between PLZF and the Rb pocket cannot be ruled out.
Oncoproteins from DNA tumour viruses such as adenovirus E1a contain an LxCxE sequence, which they use to bind Rb and inhibit its function (Felsani et al., 2006) . Cellular proteins such as HDAC1 and HDAC2 also contain an LxCxE-like sequence, which mediates their interaction with Rb (Morris and Dyson, 2001 ). The in vitro interaction between Rb and PLZF was competed by E1a (Figure 2a, lanes 3 and 4) , but not a peptide containing the LxCxE motif (Figure 2a, lanes 5 and 6) . Interestingly, although E1a displaces Rb from E2F1 (Figure 2b left panel, lanes 3 and 4) , titration with S-methionine labelled PLZF or E2F1 as indicated. GST-Rb fusion proteins were phosphorylated in vitro with a combination of cyclinD-cdk4 and cyclinE-cdk2 as described (Zarkowska and Mittnacht, 1997) . Pull-downs with GST protein alone are shown as negative controls. Inputs correspond to 10% of 35 S-methionine labelled protein as indicated. Experimental procedures and plasmids used are as described in Figure 1 , and the expression vector for E1a has been previously described (Yavuzer et al., 1995) . increasing amounts of PLZF had no effect on E2F1 binding to Rb, and a GST-Rb fusion was able to pull down both PLZF and E2F1 as a complex (Figure 2b right panel, lanes 4-6). Given that the association of Rb with E2F proteins is governed by the phosphorylation status of Rb, we tested whether this relationship also existed for the interaction between Rb and PLZF. We found that in contrast to E2F1 (Figure 2c, lane 6) , phosphorylation of Rb by cyclinE/cdk2 and cyclinD/ cdk4 slightly reduced, but did not abolish interactions with PLZF (Figure 2c, lane 3) .
Having characterized the in vitro interaction between Rb and PLZF, we extended this study including in vivo experiments. Consistent with the in vitro data, Rb and PLZF co-immunoprecipitated (Figure 3a ) and colocalized (Figure 3b ) when expressed in Rb null C33A Figure 3 In vivo analysis of interactions between retinoblastoma (Rb) and promyelocytic leukemia zinc-finger (PLZF). Rb and PLZF co-immunoprecipitate in vivo. (a) Rb and PLZF were transiently transfected (GenePorter, Genlantis, San Diego, CA, USA) into Rbnull C33A cervical carcinoma cells (also lacking PLZF expression) and co-immunoprecipitated (Catch and Release; Millipore, Billerica, MA, USA) using rabbit polyclonal anti-PLZF (H300, Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-Rb (C-15, Santa Cruz Biotechnology) antibodies. C33A cells are human papillomavirus negative (HPV-) and do not express the E7 oncoprotein, which could interfere with the properties of pRb (Crook et al., 1991) . Rabbit immunoglobulin G (IgG) was used as a negative control. Samples containing co-immunoprecipitated Rb and PLZF were resolved on a 10% SDS polyacrylamide gel and detected by immunoblotting as previously described (Petrie et al., 2003) with mouse monoclonal anti-PLZF (D-9, Santa Cruz Biotechnology) and anti-Rb (G3-245, BD Biosciences, San Jose, CA, USA) antibodies as indicated. Rb and PLZF co-localize. (b) C33A cells were transiently transfected (Lipofectamine 2000; Qiagen, Valencia, CA, USA) with PLZF and Rb (Chen et al., 1994; Chew et al., 1998) . After fixation with 4% paraformaldehyde, cells were stained with To-pro-3 iodide (Invitrogen, Carlsbad, CA, USA, stained blue) and rabbit polyclonal anti-PLZF (H300; Santa Cruz Biotechnology, shown in green) and mouse monoclonal anti-Rb (G3-245; BD Biosciences; shown in red) antibodies. Endogenous Rb and PLZF co-immunoprecipitate from KG-1 cells. (c) Endogenous Rb and PLZF were co-immunoprecipitated from KG-1 cells and blotted as described in (a). Inputs correspond to 10% of the cell lysate volume used for immuniprecipitation. Rabbit IgG was used as a negative control. PLZF is recruited to E2F/Rb target genes. (d) KG-1 cells were subjected to chromatin immunoprecipitation analysis as previously described (Guidez et al., 2005) . Soluble chromatin preparations were immunoprecipitated with mouse monoclonal anti-PLZF antibody (Koken et al., 1997) and analysed by semiquantitative PCR. The following oligonucleotide primers were used: CDC6 Fwd 5 0 -GCAGTGAGAAGGGGAACCACA-3 0 ; CDC6 Rev 5 0 -AACAAACTGCACAGCGGCAGC-3 0 ; CCNA2 Fwd 5 0 -CGTCGGGCCCTAAATCCTACC-3 0 and CCNA2 Rev 5 0 -GAGGAGGTTGCGAAAGGCGCA-3 0 . The number of cycles was determined empirically to give results that fall within the linear range of this particular PCR assay. Anti-GAL4 (DBD) antibody (RK5C1; Santa Cruz Biotechnology) was used as a negative control. Aliquots of soluble chromatin were also analysed before immunoprecipitation (Input). KG-1 cells were maintained in Iscove's modified Dulbecco's medium with 10% fetal calf serum and 1.5 g/l sodium bicarbonate and C33A cells in Dulbecco's modified Eagle's medium with 10% fetal calf serum; both media were supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin.
PLZF interactions with retinoblastoma protein K Petrie et al cervical carcinoma cells from co-transfected expression vectors. The proteins were also co-immunoprecipitated from CD34 þ KG-1 cells (Figure 3c ), in which they are endogenously expressed, indicating that the PLZF/Rb complex exists under physiological conditions in vivo. Given the in vivo association of Rb and PLZF, we examined whether PLZF could be recruited to Rb target gene promoters. As expected, PLZF was found to associate with the promoter of CCNA2, which encodes cyclin A2 (Figure 3d, left panel) . Although CCNA2 is a known PLZF target gene whose promoter contains both PLZF and E2F binding sites (Yeyati et al., 1999) , PLZF was also recruited to the promoter of CDC6 (Figure 3d , right panel), which does not contain a PLZF consensus binding site but is a known E2F/Rb target gene (Yan et al., 1998) .
Lastly, we analysed the consequences of the PLZFRb interaction for transcriptional regulation and found that co-expression with PLZF enhanced the ability of Rb to repress E2F1/DP1 mediated activation of a luciferase reporter containing an E2F1 binding site corresponding to the one found in the c-myb gene (Figure 4a ) (Mudryj et al., 1990) . Also, co-expression with Rb increased PLZF directed repression of the Hoxb2 r3/r5 enhancer, which does not contain an E2F binding site (Figure 4b ). As both PLZF and Rb effectively repress transcription from their respective reporters when transfected alone, enhanced repression arising from their co-expression may represent a reciprocal fine-tuning of the transcriptionally repressive activities of PLZF and Rb/E2F complexes. Of note, the Rb interaction region is retained in the PLZF-RARa oncoprotein (data not shown), suggesting that recruitment of Rb-containing complexes to RARa target genes and/or delocalization of Rb may be a common feature in APL with both t(15;17) and t(11;17) translocations.
Within the hematopoietic system, PLZF is expressed with a punctate nuclear distribution in CD34 þ progenitors, but not differentiated cells (Reid et al., 1995; Dai et al., 2002) , and knockout mice for PLZF and its closely related homologue FAZF (or PLZF2) both reportedly show a disruption of the balance between quiescent and cycling CD34 þ cells (Piazza et al., 2004) . Moreover, PLZF null mice (and also a model harbouring a PLZF mutation) display an agedependent loss of self-renewal in spermatagonal stem cells, likely due to uncontrolled exit from quiescence and erosion of the stem cell pool (Buaas et al., 2004; Costoya et al., 2004) . These data support the notion that PLZF serves as a growth suppressor in stem cells and are consistent with its recruitment to the promoter of the CDC6 gene, which is expressed selectively in proliferating but not quiescent cells (Yan et al., 1998) .
Although Rb is involved in multiple aspects of stem cell biology (Galderisi et al., 2006) , its contribution in early hematopoiesis remains unclear. For example, it has been reported that Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells (Walkley and Orkin, 2006) . However, Rb has also been shown to determine the choice between neutrophilic and monocytic commitment of CD34 þ progenitors (Bergh et al., 1999) and play a role in the biology of early erythroid progenitor cells, where erythropoietin induces hyperphosphorylation of Rb (Sivertsen et al., 2006) . Taken together, these data provide a plausible scenario in which interactions between PLZF and Rb play a role in stem/progenitor cell biology (such as lineage commitment, differentiation and/or self renewal, for example). Moreover, recent results indicate that, apart from their generic transcriptional activity through canonical E2F sites, the Rbbinding E2Fs can act in member-specific and cell lineage-selective ways. This is facilitated through selective partnering with other transcription factors, which in turn bring promoters with combinatorial binding sites under E2F and, hence, Rb control (Schlisio et al., 2002; Figure 4 Co-expression of retinoblastoma (Rb) and promyelocytic leukemia zinc-finger (PLZF) enhances transcriptional repression of PLZF and E2F1/Rb target genes. C33A cells were transiently transfected (Lipofectamine 2000, Qiagen) with luciferase reporters containing (a) three copies of an E2F consensus binding sequence along with mammalian expression plasmids encoding PLZF, phosphorylation-deficient Rb protein (Rb NPC ) or E2F1 and DP1 as indicated (Chen et al., 1994; Chew et al., 1998) or (b) a PLZFresponsive Hoxb2 r3/r5 enhancer luciferase reporter (Ivins et al., 2003) along with PLZF and Rb NPC as indicated. Cells were harvested 36 h after transfection and luciferase assays performed as previously described (Petrie et al., 2003) . Error bars represent standard deviations from three independent experiments each performed in triplicate. Tests for statistical significance were performed using the Mann-Whitney test (Prism 5, GraphPad Software Inc.) and asterisks (***) indicate a P-value of o0.0001. Giangrande et al., 2004; Korenjak et al., 2004) . Thus, the biological significance of the presence of PLZF in a complex with E2F proteins and Rb merits further investigation. It is interesting to speculate that PLZF could modulate the activities of E2F proteins in hematopoietic stem cells and/or progenitors through combinatorial DNA binding or serve to 'lock down' repression mediated through canonical E2F sites.
